全球脑瘤诊断市场规模、份额、趋势和成长分析报告（2026-2034年）

预计脑瘤诊断市场将从 2025 年的 24.1 亿美元成长到 2034 年的 41.3 亿美元，2026 年至 2034 年的复合年增长率为 6.17%。

由于脑肿瘤发生率不断上升以及诊断影像技术的进步，全球脑肿瘤诊断市场正稳步成长。早期准确诊断对于制定有效的治疗方案至关重要。磁振造影（MRI）、电脑断层扫描）和分子诊断检测的广泛应用推动了市场成长。人们对神经系统疾病的认识不断提高以及医疗保健服务的改善也进一步促进了市场需求的成长。

关键成长要素包括基于生物标记的检测技术和精准医疗方法的进步。医疗服务提供者正在投资高解析度成像和人工智慧辅助诊断工具，以提高检测准确率。肿瘤学领域的研究拓展和政府资助也推动了市场成长。此外，人口老化导致发病率上升，进而推高了对诊断的需求。

随着非侵入性诊断技术的不断进步，未来前景依然强劲。新兴市场正在发展医疗基础设施，这为市场成长提供了机会。人工智慧与影像分析的融合将提升早期检测能力。随着个人化癌症治疗的兴起，全球脑肿瘤诊断市场预计将稳定成长。

目录

第一章：引言

第二章执行摘要

第三章 市场变数、趋势与框架

• 市场谱系展望
• 渗透率和成长前景分析
• 价值链分析
• 法律规范
  • 标准与合规性
  • 监管影响分析
• 市场动态
  • 市场驱动因素
  • 市场限制因素
  • 市场机会
  • 市场挑战
• 波特五力分析
• PESTLE分析

第四章：全球脑肿瘤诊断市场：依诊断技术划分

• 市场分析、洞察与预测
• 医学影像技术
• 组织取样/切片检查
• 分子诊断
• 其他的

第五章 全球脑肿瘤诊断市场：依脑肿瘤类型划分

• 市场分析、洞察与预测
• 胶质瘤
• 脑膜瘤
• 脑下垂体瘤
• 其他的

第六章 全球脑肿瘤诊断市场：依最终用户划分

• 市场分析、洞察与预测
• 医院
• 诊断检查室
• 癌症医院和中心

第七章 全球脑肿瘤诊断市场：依地区划分

• 区域分析
• 北美市场分析、洞察与预测
  • 我们
  • 加拿大
  • 墨西哥
• 欧洲市场分析、洞察与预测
  • 英国
  • 法国
  • 德国
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
• 亚太市场分析、洞察与预测
  • 印度
  • 日本
  • 韩国
  • 澳洲
  • 东南亚
  • 其他亚太国家
• 拉丁美洲市场分析、洞察与预测
  • 巴西
  • 阿根廷
  • 秘鲁
  • 智利
  • 其他拉丁美洲国家
• 中东和非洲市场分析、洞察与预测
  • 沙乌地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中东和非洲国家

第八章 竞争情势

• 最新趋势
• 公司分类
• 供应链和销售管道合作伙伴（根据现有资讯）
• 市场占有率和市场定位分析（基于现有资讯）
• 供应商情况（基于现有资讯）
• 策略规划

第九章：公司简介

• 主要公司的市占率分析
• 公司简介
  • GE Healthcare
  • Siemens Healthineers
  • Philips Healthcare
  • Thermo Fisher Scientific
  • Roche Diagnostics
  • Abbott Laboratories
  • Illumina Inc
  • Hologic Inc
  • Agilent Technologies
  • Bio-Rad Laboratories

The Brain Cancer Diagnostics Market size is expected to reach USD 4.13 Billion in 2034 from USD 2.41 Billion (2025) growing at a CAGR of 6.17% during 2026-2034.

The Global Brain Cancer Diagnostics Market is growing steadily due to rising prevalence of brain tumors and advancements in diagnostic imaging technologies. Early and accurate diagnosis is crucial for effective treatment planning. Increasing adoption of MRI, CT scans, and molecular diagnostic tests is supporting market expansion. Growing awareness about neurological disorders and improved healthcare access are further driving demand.

Major growth drivers include advancements in biomarker-based testing and precision medicine approaches. Healthcare providers are investing in high-resolution imaging and AI-assisted diagnostic tools to enhance detection accuracy. Expanding research in oncology and supportive government funding are also strengthening market growth. Additionally, increasing geriatric populations are contributing to higher incidence rates, boosting diagnostic demand.

Future prospects remain strong as innovations in non-invasive diagnostic techniques continue to evolve. Emerging markets upgrading healthcare infrastructure will present growth opportunities. Integration of artificial intelligence in imaging analysis will enhance early detection capabilities. As personalized oncology gains momentum, the Global Brain Cancer Diagnostics Market is expected to expand steadily.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Diagnostic Technique

• Imaging Techniques
• Tissue Sampling/Biopsy
• Molecular Diagnostics
• Others

By Brain Cancer Type

• Gliomas
• Meningiomas
• Pituitary Tumors
• Others

By End-User

• Hospitals
• Diagnostic Laboratories
• Cancer Hospitals/Centers

COMPANIES PROFILED

• GE Healthcare, Siemens Healthineers, Philips Healthcare, Thermo Fisher Scientific, Roche Diagnostics, Abbott Laboratories, Illumina Inc, Hologic Inc, Agilent Technologies, BioRad Laboratories
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET: BY DIAGNOSTIC TECHNIQUE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Diagnostic Technique
• 4.2. Imaging Techniques Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Tissue Sampling/Biopsy Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Molecular Diagnostics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET: BY BRAIN CANCER TYPE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Brain Cancer Type
• 5.2. Gliomas Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Meningiomas Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Pituitary Tumors Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET: BY END-USER 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End-user
• 6.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Diagnostic Laboratories Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Cancer Hospitals/Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET: BY REGION 2022-2034(USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Diagnostic Technique
  • 7.2.2 By Brain Cancer Type
  • 7.2.3 By End-user
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Diagnostic Technique
  • 7.3.2 By Brain Cancer Type
  • 7.3.3 By End-user
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Diagnostic Technique
  • 7.4.2 By Brain Cancer Type
  • 7.4.3 By End-user
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Diagnostic Technique
  • 7.5.2 By Brain Cancer Type
  • 7.5.3 By End-user
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Diagnostic Technique
  • 7.6.2 By Brain Cancer Type
  • 7.6.3 By End-user
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL BRAIN CANCER DIAGNOSTICS INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 GE Healthcare
  • 9.2.2 Siemens Healthineers
  • 9.2.3 Philips Healthcare
  • 9.2.4 Thermo Fisher Scientific
  • 9.2.5 Roche Diagnostics
  • 9.2.6 Abbott Laboratories
  • 9.2.7 Illumina Inc
  • 9.2.8 Hologic Inc
  • 9.2.9 Agilent Technologies
  • 9.2.10 Bio-Rad Laboratories